H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17975751
[patent_doc_number] => 11492601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Multiple host range bacteriophage with hybrid tail fibres
[patent_app_type] => utility
[patent_app_number] => 15/517664
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 48
[patent_no_of_words] => 15295
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517664 | Multiple host range bacteriophage with hybrid tail fibres | Oct 7, 2015 | Issued |
Array
(
[id] => 11993964
[patent_doc_number] => 20170298120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/515746
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39777
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515746
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515746 | Antibodies that bind Ebola glycoprotein and uses thereof | Oct 1, 2015 | Issued |
Array
(
[id] => 11949521
[patent_doc_number] => 20170253673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'STIMULI-RESPONSIVE PROTEIN-POLYMER CONJUGATES FOR BIOSEPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/515936
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18710
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515936 | STIMULI-RESPONSIVE PROTEIN-POLYMER CONJUGATES FOR BIOSEPARATION | Sep 29, 2015 | Abandoned |
Array
(
[id] => 11018069
[patent_doc_number] => 20160215023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 14/870759
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23629
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14870759
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/870759 | SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES | Sep 29, 2015 | Abandoned |
Array
(
[id] => 11895380
[patent_doc_number] => 09765305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Mutant vaccinia virus strains, uses thereof and method of producing the same'
[patent_app_type] => utility
[patent_app_number] => 14/863330
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5499
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863330
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863330 | Mutant vaccinia virus strains, uses thereof and method of producing the same | Sep 22, 2015 | Issued |
Array
(
[id] => 11937882
[patent_doc_number] => 20170242032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'METHOD FOR ANALYSING AGGREGATES IN ANTIBODY SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 15/512505
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3895
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512505
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512505 | METHOD FOR ANALYSING AGGREGATES IN ANTIBODY SAMPLES | Sep 21, 2015 | Abandoned |
Array
(
[id] => 14977925
[patent_doc_number] => 10442863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Construct for the delivery of a molecule into the cytoplasm of a cell
[patent_app_type] => utility
[patent_app_number] => 15/509018
[patent_app_country] => US
[patent_app_date] => 2015-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26690
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509018 | Construct for the delivery of a molecule into the cytoplasm of a cell | Sep 6, 2015 | Issued |
Array
(
[id] => 11956104
[patent_doc_number] => 20170260255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'FUSION PROTEIN AND PURIFYING METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/509105
[patent_app_country] => US
[patent_app_date] => 2015-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9017
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509105
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509105 | FUSION PROTEIN AND PURIFYING METHOD | Sep 6, 2015 | Abandoned |
Array
(
[id] => 11970146
[patent_doc_number] => 20170274299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'METHOD FOR PURIFICATION OF MONOCLONAL ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/508577
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19554
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508577 | Method for purification of monoclonal antibodies | Sep 3, 2015 | Issued |
Array
(
[id] => 10715682
[patent_doc_number] => 20160061830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'BACTERIOPHAGE-BASED BIOSENSOR FOR MICROBIAL DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/837621
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4478
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/837621 | Bacteriophage-based biosensor for microbial detection | Aug 26, 2015 | Issued |
Array
(
[id] => 12058603
[patent_doc_number] => 20170334947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'AFFINITY SEPARATION MATRIX FOR FAB REGION-CONTAINING PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/506657
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20515
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506657 | AFFINITY SEPARATION MATRIX FOR FAB REGION-CONTAINING PEPTIDE | Aug 26, 2015 | Abandoned |
Array
(
[id] => 13856337
[patent_doc_number] => 10189877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Tetravalent dengue vaccine
[patent_app_type] => utility
[patent_app_number] => 15/506379
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 4
[patent_no_of_words] => 5654
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506379 | Tetravalent dengue vaccine | Aug 20, 2015 | Issued |
Array
(
[id] => 10692440
[patent_doc_number] => 20160038586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'Virus-like Particle Vaccines'
[patent_app_type] => utility
[patent_app_number] => 14/819684
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18307
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819684
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/819684 | Virus-like Particle Vaccines | Aug 5, 2015 | Abandoned |
Array
(
[id] => 15338931
[patent_doc_number] => 10525122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Vaccine containing virus-like particles
[patent_app_type] => utility
[patent_app_number] => 15/326143
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20840
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326143 | Vaccine containing virus-like particles | Jul 14, 2015 | Issued |
Array
(
[id] => 16634337
[patent_doc_number] => 10912824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Vector production
[patent_app_type] => utility
[patent_app_number] => 15/325124
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10523
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325124 | Vector production | Jul 12, 2015 | Issued |
Array
(
[id] => 14291907
[patent_doc_number] => 10286061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Immunogenic influenza composition
[patent_app_type] => utility
[patent_app_number] => 14/793732
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17496
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793732
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793732 | Immunogenic influenza composition | Jul 6, 2015 | Issued |
Array
(
[id] => 10489787
[patent_doc_number] => 20150374807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'Amyloid beta1-6 Antigen Arrays'
[patent_app_type] => utility
[patent_app_number] => 14/788896
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 38252
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14788896
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/788896 | Amyloid beta1-6 Antigen Arrays | Jun 30, 2015 | Abandoned |
Array
(
[id] => 10412683
[patent_doc_number] => 20150297692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant'
[patent_app_type] => utility
[patent_app_number] => 14/751492
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8087
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751492
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/751492 | Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant | Jun 25, 2015 | Abandoned |
Array
(
[id] => 11743989
[patent_doc_number] => 20170198061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'INFLUENZA VACCINES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/320679
[patent_app_country] => US
[patent_app_date] => 2015-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10646
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320679 | INFLUENZA VACCINES AND METHODS OF USE THEREOF | Jun 19, 2015 | Abandoned |
Array
(
[id] => 11625925
[patent_doc_number] => 20170136114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/319856
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 15101
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319856 | Attenuated African swine fever virus vaccine | Jun 18, 2015 | Issued |